Form 4: Evolv Technologies Insider Sells Shares

Evolv Technologies' Founder and Chief Innovation Officer, Michael Ellenbogen, exercised options and sold 80,745 Class A Common Stock shares.

Summary

• Michael Ellenbogen, Founder & Chief Innovation Officer and a Director of Evolv Technologies Holdings, Inc. [EVLV], reported transactions on September 15, 2025.
• Ellenbogen acquired 80,745 shares of Class A Common Stock by exercising stock options at a price of $0.24 per share.
• Concurrently, he disposed of 80,745 shares of Class A Common Stock at a weighted average price of $8.46 per share.
• The sales were executed pursuant to a Rule 10b5-1 trading plan established on June 12, 2025.
• Following these transactions, Ellenbogen directly beneficially owns 2,083,961 shares of Class A Common Stock.
• Additionally, 151,135 shares are indirectly held by the Family Horizon Trust.
• Ellenbogen also holds 1,623,719 stock options (right to buy) with an exercise price of $0.24, which vested over time, starting with 25% on January 31, 2018, and then in 36 equal monthly installments.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic selling. The significant profit from option exercise also reflects positively on the value created for the executive.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale rather than a reaction to new, non-public information, which can mitigate negative market perception.
• The significant difference between the option exercise price ($0.24) and the sale price ($8.46) highlights substantial value creation for the insider from their equity compensation.

Negatives

• The sale of 80,745 shares by a key executive (Founder & Chief Innovation Officer) could be interpreted by some investors as a lack of confidence, even if pre-planned.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing reflects a routine insider transaction for liquidity and diversification purposes, common among executives in publicly traded technology companies like Evolv Technologies. It does not provide insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders may view the insider sale with mixed sentiment; some may see it as a routine liquidity event, while others might interpret it as a signal of reduced confidence, despite the 10b5-1 plan.
• The transaction primarily impacts the reporting person's personal financial holdings and does not directly affect employees, customers, suppliers, or creditors.

Key Dates

Recommendation

This Form 4 reports a pre-planned insider transaction (exercise and sale) by a key executive. While insider selling can sometimes be a negative signal, the execution under a Rule 10b5-1 plan suggests a scheduled liquidity event rather than a reaction to new, adverse information. The transaction itself does not provide sufficient new information to warrant a change in investment thesis for Evolv Technologies. Investors should continue to monitor the company's operational performance and broader market trends.

Keywords

Evolv Technologies, EVLV, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Michael Ellenbogen, Rule 10b5-1 Plan, Corporate Governance